C3a Receptors Signaling in Mast Cells

  • Asifa K. Zaidi
  • Hydar Ali
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 598)


Mast Cell Cystic Fibrosis Transmembrane Conductance Regulator Airway Smooth Muscle Allergy Clin Immunol Human Mast Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahamed J. and Ali H. (2002) Distinct Roles of Receptor Phosphorylation, G Protein Usage, and Mitogen-activated Protein Kinase Activation on Platelet Activating Factor-induced Leukotriene C4 Generation and Chemokine Production. J Biol Chem 277, 22685-91.PubMedCrossRefGoogle Scholar
  2. Ahamed J., Haribabu B. and Ali H. (2001) Cutting edge: Differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation. J Immunol 167, 3559-63.PubMedGoogle Scholar
  3. Ahamed J., Venkatesha R. T., Thangam E. B. and Ali H. (2004) C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1. J Immunol 172, 6961-8.PubMedGoogle Scholar
  4. Ali H., Ahamed J., Hernandez-Munain C., Baron J. L., Krangel M. S. and Patel D. D. (2000) Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT. J Immunol 165, 7215-23.PubMedGoogle Scholar
  5. Ali H., Haribabu B., Richardson R. M. and Snyderman R. (1997) Mechanisms of inflammation and leukocyte activation. Med Clin North Am 81, 1-28.PubMedCrossRefGoogle Scholar
  6. Ali H. and Panettieri R. A., Jr. (2005) Anaphylatoxin C3a receptors in asthma. Respir Res 6, 19.PubMedCrossRefGoogle Scholar
  7. Baelder R., Fuchs B., Bautsch W., Zwirner J., Kohl J., Hoymann H. G., Glaab T., Erpenbeck V., Krug N. and Braun A. (2005) Pharmacological Targeting of Anaphylatoxin Receptors during the Effector Phase of Allergic Asthma Suppresses Airway Hyperresponsiveness and Airway Inflammation. J Immunol 174, 783-9.PubMedGoogle Scholar
  8. Bani D., Nistri S., Mannaioni P. F. and Masini E. (2006) Cardiac anaphylaxis: pathophysiology and therapeutic perspectives. Curr Allergy Asthma Rep 6, 14-9.PubMedCrossRefGoogle Scholar
  9. Bao L., Osawe I., Haas M. and Quigg R. J. (2005) Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis. J Immunol 175, 1947-55.PubMedGoogle Scholar
  10. Bautsch W., Hoymann H. G., Zhang Q., Meier-Wiedenbach I., Raschke U., Ames R. S., Sohns B., Flemme N., Meyer Zu Vilsendorf A., Grove M., Klos A. and Kohl J. (2000) Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma [In Process Citation]. J Immunol 165, 5401-5.PubMedGoogle Scholar
  11. Becamel C., Galeotti N., Poncet J., Jouin P., Dumuis A., Bockaert J. and Marin P. (2002) A proteomic approach based on peptide affinity chromatography, 2-dimensional electrophoresis and mass spectrometry to identify multiprotein complexes interacting with membrane-bound receptors. Biol Proced Online 4, 94-104.PubMedCrossRefGoogle Scholar
  12. Bertin J., Wang L., Guo Y., Jacobson M. D., Poyet J. L., Srinivasula S. M., Merriam S., DiStefano P. S. and Alnemri E. S. (2001) CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 276, 11877-82.PubMedCrossRefGoogle Scholar
  13. Bhattacharya M., Anborgh P. H., Babwah A. V., Dale L. B., Dobransky T., Benovic J. L., Feldman R. D., Verdi J. M., Rylett R. J. and Ferguson S. S. (2002) Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4, 547-55.PubMedGoogle Scholar
  14. Bockaert J., Roussignol G., Becamel C., Gavarini S., Joubert L., Dumuis A., Fagni L. and Marin P. (2004) GPCR-interacting proteins (GIPs): nature and functions. Biochem Soc Trans 32, 851-5.PubMedCrossRefGoogle Scholar
  15. Boos L., Szalai A. J. and Barnum S. R. (2005) C3a expressed in the central nervous system protects against LPS-induced shock. Neurosci Lett 387, 68-71.PubMedCrossRefGoogle Scholar
  16. Brightling C. E., Ammit A. J., Kaur D., Black J. L., Wardlaw A. J., Hughes J. M. and Bradding P. (2005a) The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171, 1103-8.CrossRefGoogle Scholar
  17. Brightling C. E. and Bradding P. (2005) The Re-emergence of the Mast Cell As a Pivotal Cell in Asthma Pathogenesis. Curr Allergy Asthma Rep 5, 130-5.PubMedCrossRefGoogle Scholar
  18. Brightling C. E., Bradding P., Symon F. A., Holgate S. T., Wardlaw A. J. and Pavord I. D. (2002) Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346, 1699-705.PubMedCrossRefGoogle Scholar
  19. Brightling C. E., Kaur D., Berger P., Morgan A. J., Wardlaw A. J. and Bradding P. (2005b) Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leukoc Biol.Google Scholar
  20. Brightling C. E., Symon F. A., Holgate S. T., Wardlaw A. J., Pavord I. D. and Bradding P. (2003) Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy 33, 1711-6.PubMedCrossRefGoogle Scholar
  21. Carroll N. G., Mutavdzic S. and James A. L. (2002) Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J 19, 879-85.PubMedCrossRefGoogle Scholar
  22. Casolaro V., Galeone D., Giacummo A., Sanduzzi A., Melillo G. and Marone G. (1989) Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 139, 1375-82.PubMedGoogle Scholar
  23. Castro F. F., Schmitz-Schumann M., Rother U. and Kirschfink M. (1991) Complement activation by house dust: reduced reactivity of serum complement in patients with bronchial asthma. Int Arch Allergy Appl Immunol 96, 305-10.PubMedGoogle Scholar
  24. Chen W., Hu L. A., Semenov M. V., Yanagawa S., Kikuchi A., Lefkowitz R. J. and Miller W. E. (2001) beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins. Proc Natl Acad Sci U S A 98, 14889-94.PubMedCrossRefGoogle Scholar
  25. Choi W. S., Kim Y. M., Combs C., Frohman M. A. and Beaven M. A. (2002) Phospholipases D1 and D2 regulate different phases of exocytosis in mast cells. J Immunol 168, 5682-9.PubMedGoogle Scholar
  26. Drouin S. M., Corry D. B., Hollman T. J., Kildsgaard J. and Wetsel R. A. (2002) Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 169, 5926-33.PubMedGoogle Scholar
  27. Drouin S. M., Corry D. B., Kildsgaard J. and Wetsel R. A. (2001) Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J Immunol 167, 4141-5.PubMedGoogle Scholar
  28. Echtenacher B., Mannel D. N. and Hultner L. (1996) Critical protective role of mast cells in a model of acute septic peritonitis [see comments]. Nature 381, 75-7.PubMedCrossRefGoogle Scholar
  29. el-Lati S. G., Dahinden C. A. and Church M. K. (1994) Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102, 803-6.PubMedCrossRefGoogle Scholar
  30. Estell K., Braunstein G., Tucker T., Varga K., Collawn J. F. and Schwiebert L. M. (2003) Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. Mol Cell Biol 23, 594-606.PubMedCrossRefGoogle Scholar
  31. Fernandez N., Monczor F., Lemos B., Notcovich C., Baldi A., Davio C. and Shayo C. (2002) Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation. Mol Pharmacol 62, 1506-14.PubMedCrossRefGoogle Scholar
  32. Fong A. M., Premont R. T., Richardson R. M., Yu Y. R., Lefkowitz R. J. and Patel D. D. (2002) Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci U S A 99, 7478-83.PubMedCrossRefGoogle Scholar
  33. Freedman N. J. and Lefkowitz R. J. (1996) Desensitization of G protein-coupled receptors. Recent Prog Horm Res 51, 319-51; discussion 352-3.PubMedGoogle Scholar
  34. Fregonese L., Swan F. J., Van Schadewijk A., Dolhnikoff M., Santos M. A., Daha M. R., Stolk J., Tschernig T., Sterk P. J., Hiemstra P. S., Rabe K. F. and Mauad T. (2005) Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. J Allergy Clin Immunol 115, 1148-54.PubMedCrossRefGoogle Scholar
  35. Fureder W., Agis H., Willheim M., Bankl H. C., Maier U., Kishi K., Muller M. R., Czerwenka K., Radaszkiewicz T., Butterfield J. H. Klappacher G. W., Sperr W. R., Oppermann M., Lechner K. and Valent P. (1995) Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 155, 3152-60.PubMedGoogle Scholar
  36. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B. and Pei G. (2004) Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol Cell 14, 303-17.PubMedCrossRefGoogle Scholar
  37. Geijsen N., Uings I. J., Pals C., Armstrong J., McKinnon M., Raaijmakers J. A., Lammers J. W., Koenderman L. and Coffer P. J. (2001) Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 293, 1136-8.PubMedCrossRefGoogle Scholar
  38. Ghosh S. and Karin M. (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl, S81-96.PubMedCrossRefGoogle Scholar
  39. Gibson P. G., Allen C. J., Yang J. P., Wong B. J., Dolovich J., Denburg J. and Hargreave F. E. (1993) Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am Rev Respir Dis 148, 80-6.PubMedGoogle Scholar
  40. Gonzalez-Espinosa C., Odom S., Olivera A., Hobson J. P., Martinez M. E., Oliveira-Dos-Santos A., Barra L., Spiegel S., Penninger J. M. and Rivera J. (2003) Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells. J Exp Med 197, 1453-65.PubMedCrossRefGoogle Scholar
  41. Gutzmer R., Lisewski M., Zwirner J., Mommert S., Diesel C., Wittmann M., Kapp A. and Werfel T. (2004) Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons. Immunology 111, 435-43.PubMedCrossRefGoogle Scholar
  42. Haczku A., Atochina E. N., Tomer Y., Chen H., Scanlon S. T., Russo S., Xu J., Panettieri R. A., Jr. and Beers M. F. (2001) Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol 25, 45-50.PubMedGoogle Scholar
  43. Hartmann K., Henz B. M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., Haase I., Lippert U. and Zuberbier T. (1997) C3a and C5a stimulate chemotaxis of human mast cells. Blood 89, 2863-70.PubMedGoogle Scholar
  44. Hasegawa K., Tamari M., Shao C., Shimizu M., Takahashi N., Mao X. Q., Yamasaki A., Kamada F., Doi S., Fujiwara H., Miyatake A., Fujita K., Tamura G., Matsubara Y., Shirakawa T. and Suzuki Y. (2004) Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum Genet 115, 295-301.PubMedCrossRefGoogle Scholar
  45. Humbles A. A., Lu B., Nilsson C. A., Lilly C., Israel E., Fujiwara Y., Gerard N. P. and Gerard C. (2000) A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406, 998-1001.PubMedCrossRefGoogle Scholar
  46. Hundley T. R., Prasad A. R. and Beaven M. A. (2001) Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase. J Immunol 167, 1629-36.PubMedGoogle Scholar
  47. Hung A. Y. and Sheng M. (2002) PDZ domains: structural modules for protein complex assembly. J Biol Chem 277, 5699-702.PubMedCrossRefGoogle Scholar
  48. Irani A. A., Schechter N. M., Craig S. S., DeBlois G. and Schwartz L. B. (1986) Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 83, 4464-8.PubMedCrossRefGoogle Scholar
  49. Irani A. M., Bradford T. R., Kepley C. L., Schechter N. M. and Schwartz L. B. (1989) Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37, 1509-15.PubMedGoogle Scholar
  50. Juliusson S., Pipkorn U., Karlsson G. and Enerback L. (1992) Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 90, 898-909.PubMedCrossRefGoogle Scholar
  51. Kawamoto S., Yalcindag A., Laouini D., Brodeur S., Bryce P., Lu B., Humbles A. A., Oettgen H., Gerard C. and Geha R. S. (2004) The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J Clin Invest 114, 399-407.PubMedCrossRefGoogle Scholar
  52. Kildsgaard J., Hollmann T. J., Matthews K. W., Bian K., Murad F. and Wetsel R. A. (2000) Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock [In Process Citation]. J Immunol 165, 5406-9.PubMedGoogle Scholar
  53. Kim J., Ahn S., Ren X. R., Whalen E. J., Reiter E., Wei H. and Lefkowitz R. J. (2005) Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci U S A 102, 1442-7.PubMedCrossRefGoogle Scholar
  54. Kirchhoff K., Weinmann O., Zwirner J., Begemann G., Gotze O., Kapp A. and Werfel T. (2001) Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology 103, 210-7.PubMedCrossRefGoogle Scholar
  55. Kohl J., Baelder R., Lewkowich I. P., Pandey M. K., Hawlisch H., Wang L., Best J., Herman N. S., Sproles A. A., Zwirner J., Whitsett J. A., Gerard C., Sfyroera G., Lambris J. D. and Wills-Karp M. (2006) A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J Clin Invest 116, 783-96.PubMedCrossRefGoogle Scholar
  56. Lambrecht B. N. (2006) An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization. J Clin Invest 116, 628-32.PubMedCrossRefGoogle Scholar
  57. Langkabel P., Zwirner J. and Oppermann M. (1999) Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by “G protein-coupled receptor kinases. Eur J Immunol 29, 3035-46.PubMedCrossRefGoogle Scholar
  58. Li Z., Jiang H., Xie W., Zhang Z., Smrcka A. V. and Wu D. (2000) Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction [see comments]. Science 287, 1046-9.PubMedCrossRefGoogle Scholar
  59. Lombardi M. S., Kavelaars A., Schedlowski M., Bijlsma J. W., Okihara K. L., Van de Pol M., Ochsmann S., Pawlak C., Schmidt R. E. and Heijnen C. J. (1999) Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. Faseb J 13, 715-25.PubMedGoogle Scholar
  60. Marone G., de Crescenzo G., Adt M., Patella V., Arbustini E. and Genovese A. (1995) Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 31, 1-18.PubMedCrossRefGoogle Scholar
  61. Marone G., Triggiani M. and de Paulis A. (2005) Mast cells and basophils: friends as well as foes in bronchial asthma? Trends Immunol 26, 25-31.PubMedCrossRefGoogle Scholar
  62. Marshall J. S. and Jawdat D. M. (2004) Mast cells in innate immunity. J Allergy Clin Immunol 114, 21-7.PubMedCrossRefGoogle Scholar
  63. Maruotti N., Crivellato E., Cantatore F. P., Vacca A. and Ribatti D. (2006) Mast cells in rheumatoid arthritis. Clin Rheumatol.Google Scholar
  64. Miller W. E. and Lefkowitz R. J. (2001) Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol 13, 139-45.PubMedCrossRefGoogle Scholar
  65. Nakano Y., Morita S., Kawamoto A., Suda T., Chida K. and Nakamura H. (2003) Elevated complement C3a in plasma from patients with severe acute asthma. J Allergy Clin Immunol 112, 525-30.PubMedCrossRefGoogle Scholar
  66. Nilsson G., Johnell M., Hammer C. H., Tiffany H. L., Nilsson K., Metcalfe D. D., Siegbahn A. and Murphy P. M. (1996) C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157, 1693-8.PubMedGoogle Scholar
  67. Oskeritzian C. A., Zhao W., Min H. K., Xia H. Z., Pozez A., Kiev J. and Schwartz L. B. (2005) Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol 115, 1162-8.PubMedCrossRefGoogle Scholar
  68. Page S., Ammit A. J., Black J. L. and Armour C. L. (2001) Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol 281, L1313-23.PubMedGoogle Scholar
  69. Panettieri R. A., Jr. (2003) Airway smooth muscle: immunomodulatory cells that modulate airway remodeling? Respir Physiol Neurobiol 137, 277-93.PubMedCrossRefGoogle Scholar
  70. Peng T., Hao L., Madri J. A., Su X., Elias J. A., Stahl G. L., Squinto S. and Wang Y. (2005) Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J Clin Invest 115, 1590-600.PubMedCrossRefGoogle Scholar
  71. Penn R. B., Pronin A. N. and Benovic J. L. (2000) Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 10, 81-9.PubMedCrossRefGoogle Scholar
  72. Pomerantz J. L., Denny E. M. and Baltimore D. (2002) CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. Embo J 21, 5184-94.PubMedCrossRefGoogle Scholar
  73. Ren X. R., Reiter E., Ahn S., Kim J., Chen W. and Lefkowitz R. J. (2005) Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci U S A 102, 1448-53.PubMedCrossRefGoogle Scholar
  74. Robinson D. S. (2004) The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? J Allergy Clin Immunol 114, 58-65.PubMedCrossRefGoogle Scholar
  75. Santini F., Penn R. B., Gagnon A. W., Benovic J. L. and Keen J. H. (2000) Selective recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled receptors. J Cell Sci 113, 2463-70.PubMedGoogle Scholar
  76. Sayama K., Diehn M., Matsuda K., Lunderius C., Tsai M., Tam S. Y., Botstein D., Brown P. O. and Galli S. J. (2002) Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. BMC Immunol 3, 5.PubMedCrossRefGoogle Scholar
  77. Schuh J. M., Blease K., Kunkel S. L. and Hogaboam C. M. (2002) Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus. Am J Physiol Lung Cell Mol Physiol 283, L198-204.PubMedGoogle Scholar
  78. Schulman E. S., Post T. J., Henson P. M. and Giclas P. C. (1988) Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 81, 918-23.PubMedGoogle Scholar
  79. Settmacher B., Rheinheimer C., Hamacher H., Ames R. S., Wise A., Jenkinson L., Bock D., Schaefer M., Kohl J. and Klos A. (2003) Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling. Eur J Immunol 33, 920-7.PubMedCrossRefGoogle Scholar
  80. Soruri A., Kiafard Z., Dettmer C., Riggert J., Kohl J. and Zwirner J. (2003) IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo. J Immunol 170, 3306-14.PubMedGoogle Scholar
  81. Strunk R. C., Eidlen D. M. and Mason R. J. (1988) Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 81, 1419-26.PubMedCrossRefGoogle Scholar
  82. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C. and Ogawa H. (2001) Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167, 2250-6.PubMedGoogle Scholar
  83. Taube C., Rha Y. H., Takeda K., Park J. W., Joetham A., Balhorn A., Dakhama A., Giclas P. C., Holers V. M. and Gelfand E. W. (2003) Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 168, 1333-41.PubMedCrossRefGoogle Scholar
  84. Taube C., Wei X., Swasey C. H., Joetham A., Zarini S., Lively T., Takeda K., Loader J., Miyahara N., Kodama T., Shultz L. D., Donaldson D. D., Hamelmann E. H., Dakhama A. and Gelfand E. W. (2004) Mast cells, FcepsilonRI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 172, 6398-406.PubMedGoogle Scholar
  85. ter Laan B., Molenaar J. L., Feltkamp-Vroom T. M. and Pondman K. W. (1974) Interaction of human anaphylatoxin C3a with rat mast cells demonstrated by immunofluorescence. Eur J Immunol 4, 393-5.PubMedCrossRefGoogle Scholar
  86. Thangam E. B., Venkatesha R. T., Zaidi A. K., Jordan-Sciutto K. L., Goncharov D. A., Krymskaya V. P., Amrani Y., Panettieri R. A., Jr. and Ali H. (2005) Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. Faseb J 19, 798-800.PubMedGoogle Scholar
  87. Tkaczyk C., Beaven M. A., Brachman S. M., Metcalfe D. D. and Gilfillan A. M. (2003) The PLCgamma 1-dependent pathway of Fcepsilon RI-mediated mast cell activation is regulated independently of PI-3 kinase. J Biol Chem.Google Scholar
  88. Vandermeer J., Sha Q., Lane A. P. and Schleimer R. P. (2004) Innate immunity of the sinonasal cavity: expression of messenger RNA for complement cascade components and toll-like receptors. Arch Otolaryngol Head Neck Surg 130, 1374-80.PubMedCrossRefGoogle Scholar
  89. Varsano S., Kaminsky M., Kaiser M. and Rashkovsky L. (2000) Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line. Thorax 55, 364-9.PubMedCrossRefGoogle Scholar
  90. Venkatesha R. T., Ahamed J., Nuesch C., Zaidi A. K. and Ali H. (2004) Platelet-activating Factor-induced Chemokine Gene Expression Requires NF-{kappa}B Activation and Ca2+/Calcineurin Signaling Pathways: INHIBITION BY RECEPTOR PHOSPHORYLATION AND {beta}-ARRESTIN RECRUITMENT. J Biol Chem 279, 44606-44612.Google Scholar
  91. Venkatesha R. T., Berla Thangam E., Zaidi A. K. and Ali H. (2005a) Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 42, 581-7.CrossRefGoogle Scholar
  92. Venkatesha R. T., Thangam E. B., Zaidi A. K. and Ali H. (2005b) Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 42, 581-7.CrossRefGoogle Scholar
  93. Werfel T., Kirchhoff K., Wittmann M., Begemann G., Kapp A., Heidenreich F., Gotze O. and Zwirner J. (2000) Activated human T lymphocytes express a functional C3a receptor. J Immunol 165, 6599-605.PubMedGoogle Scholar
  94. Williams C. M. and Galli S. J. (2000) Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192, 455-62.PubMedCrossRefGoogle Scholar
  95. Wills-Karp M. and Koehl J. (2005) New Insights into the Role of the Complement Pathway in Allergy and Asthma. Curr Allergy Asthma Rep 5, 362-369.PubMedCrossRefGoogle Scholar
  96. Witherow D. S., Garrison T. R., Miller W. E. and Lefkowitz R. J. (2004) beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc Natl Acad Sci U S A.Google Scholar
  97. Woolhiser M. R., Brockow K. and Metcalfe D. D. (2004) Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. Clin Immunol 110, 172-80.PubMedCrossRefGoogle Scholar
  98. Xia H. Z., Kepley C. L., Sakai K., Chelliah J., Irani A. M. and Schwartz L. B. (1995) Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 154, 5472-80.PubMedGoogle Scholar
  99. Yu M., Tsai M., Tam S. Y., Jones C., Zehnder J. and Galli S. J. (2006) Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116, 1633-41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Asifa K. Zaidi
    • 1
  • Hydar Ali
    • 1
  1. 1.Department of PathologyUniversity of Pennsylvania School of Dental MedicinePhiladelphia

Personalised recommendations